Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-6-10
pubmed:abstractText
A prospective phase II study was performed to determine the feasibility, efficacy and safety of arterial hepatic infusion (HAI) using pirarubicin combined with intravenous chemotherapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
856-63
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12796022-Adolescent, pubmed-meshheading:12796022-Adult, pubmed-meshheading:12796022-Aged, pubmed-meshheading:12796022-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12796022-Chemotherapy, Adjuvant, pubmed-meshheading:12796022-Colorectal Neoplasms, pubmed-meshheading:12796022-Disease Progression, pubmed-meshheading:12796022-Doxorubicin, pubmed-meshheading:12796022-Feasibility Studies, pubmed-meshheading:12796022-Female, pubmed-meshheading:12796022-Fluorouracil, pubmed-meshheading:12796022-Hepatic Artery, pubmed-meshheading:12796022-Humans, pubmed-meshheading:12796022-Infusions, Intra-Arterial, pubmed-meshheading:12796022-Leucovorin, pubmed-meshheading:12796022-Liver Neoplasms, pubmed-meshheading:12796022-Male, pubmed-meshheading:12796022-Middle Aged, pubmed-meshheading:12796022-Prospective Studies, pubmed-meshheading:12796022-Survival Rate, pubmed-meshheading:12796022-Time Factors
pubmed:year
2003
pubmed:articleTitle
Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer.
pubmed:affiliation
Institut Gustave Roussy, Villejuif, France.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Multicenter Study, Clinical Trial, Phase II